Начало › Сърдечна недостатъчност › Калифорния › San Francisco
Клинични проучвания за Сърдечна недостатъчност в San Francisco, CA
29 проучвания за Сърдечна недостатъчност търсят участници в обекти в и около San Francisco (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
ELEVATE-HFpEF Clinical Study
Набиране на участници
- Sutter Health Hospital, San Francisco
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Набиране на участнициФаза 3
- Research Site, San Francisco
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Набиране на участнициФаза 2
- University of California, San Francisco, San Francisco
- University of California San Francisco UCSF, San Francisco
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Набиране на участнициФаза 3
- California Pacific Medical Center Van Ness Campus, San Francisco
Alleviant ALLAY-HFrEF Study
Набиране на участници
- University of California San Francisco, San Francisco
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Набиране на участнициФаза 3
- Kaiser Permanente, San Francisco
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Набиране на участнициФаза 3
- Research Site, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Набиране на участнициФаза 3
- San Francisco, CA Investigative Site CON-10315, San Francisco
- CON-10023, San Francisco, CA, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Набиране на участнициФаза 3
- San Francisco, CA Investigative Site 10023, San Francisco
Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure
Набиране на участници
- University of California, San Francisco, San Francisco
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Набиране на участнициФаза 2
- University of California, San Francisco - Heart and Vascular Center, San Francisco
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Набиране на участници
- Zuckerberg San Francisco General, San Francisco
- University of California San Francisco, San Francisco
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Набиране на участнициНаблюдателно проучване
- University Of California San Francisco Medical Center, San Francisco
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Набиране на участнициФаза 3
- Tenax Investigational Site, San Francisco
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Набиране на участнициФаза 3
- Kaiser Permanente Northern California, San Francisco
- San Francisco V.A. Medical Center, San Francisco
Alleviant ALLAY-HF Study
Набиране на участници
- University of California San Francisco, San Francisco
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Набиране на участнициФаза 3
- UC San Francisco Medical Center, San Francisco
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Набиране на участнициФаза 3
- San Francisco, CA Investigative Site FIN-10023, San Francisco
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Набиране на участници
- UCSF Medical Center, San Francisco
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Набиране на участници
- University of California at San Francisco, San Francisco
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Набиране на участнициФаза 3
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Developing a Digital Aid to Improve ICD Decisions
Набиране на участници
- University of California, San Francisco, San Francisco
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Набиране на участници
- University of California- San Francisco, San Francisco
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
Набиране на участнициНаблюдателно проучване
- University of California, San Francisco (UCSF), San Francisco
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Набиране на участнициНаблюдателно проучване
- UCSF, San Francisco
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Набиране на участнициНаблюдателно проучване
- University of California, San Francisco, San Francisco
- Kaiser Permanente San Francisco, San Francisco
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Набиране на участнициФаза 1
- University of California San Francisco, San Francisco
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Набиране на участнициНаблюдателно проучване
- University of California San Francisco, San Francisco
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Набиране на участнициФаза 1/2
- University of California, San Francisco, San Francisco
Проучвания за Сърдечна недостатъчност в други градове
- New York City, NY51 проучвания
- Boston, MA44 проучвания
- Dallas, TX42 проучвания
- Houston, TX36 проучвания
- Cleveland, OH33 проучвания
- Chicago, IL31 проучвания
- Philadelphia, PA31 проучвания
- St. Louis, MO26 проучвания
- Durham, NC26 проучвания
- Atlanta, GA25 проучвания
- Kansas City, MO25 проучвания
- Baltimore, MD24 проучвания
Други проучвания в San Francisco
- Рак на простатата45 проучвания
- Рак на гърдата43 проучвания
- Рак на белия дроб с недребноклетъчен тип36 проучвания
- Рак (всички видове)35 проучвания
- Метастатичен рак28 проучвания
- Рак на белия дроб23 проучвания
- Меланом22 проучвания
- Рак на панкреаса20 проучвания
- Рак на яйчниците19 проучвания
- Колоректален рак18 проучвания
- Сърдечно-съдово заболяване18 проучвания
- Глиобластом17 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.